Navigation Links
Studies assess genetics, modified treatment to improve outcomes, reduce toxicity
Date:12/8/2012

on-daunorubicin arms, respectively. Measurements of minimal residual disease, in which a small number of leukemic cells remain during treatment, were also equivalent in the two study arms. These results demonstrate similar efficacy rates of treatment strategies for standard-risk ALL that do or do not include induction treatment with daunorubicin.

"Our study data have the potential to benefit children with ALL in two important ways," said Andre Baruchel, MD, lead author and Head of the Department of Pediatric Hematology at the Robert Debr University Hospital (Assistance Publique Hpitaux de Paris) in Paris. "First, we now have strong evidence that reducing the amount of chemotherapy initially administered to these children, who constitute the majority of ALL patients, does not negatively affect their immediate outcome. Perhaps more importantly, we know and anticipate that removing harmful chemotherapy from their treatment can help minimize their risk of experiencing heart damage later in life."

Dr. Baruchel will present this study in an oral presentation on Sunday, December 9, at 5:00 p.m. EST at the Georgia World Congress Center in Room A103, Level 1, Building A.

ATRA and Arsenic Trioxide (ATO) Versus ATRA and Idarubicin (AIDA) for Newly Diagnosed, Non High-Risk Acute Promyelocytic Leukemia (APL): Results of the Phase III, Prospective, Randomized, Intergroup APL0406 Study by the Italian-German Cooperative Groups Gimema-SAL-AMLSG [Abstract 6]

New research demonstrates the efficacy of the first curative treatment for acute promyelocytic leukemia (APL) that does not include chemotherapy, marking an important step toward front-line use of targeted therapies for acute leukemia.

APL is an uncommon, yet aggressive, subtype of acute myeloid leukemia (AML) in which there are too many immature white blood cells in the bone marrow
'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
614-352-5096
American Society of Hematology
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. John Theurer Cancer Center to present 37 studies at the 2012 ASH Annual Meeting
2. Benefit6 Whole Body Protection, a New Product by I Do Strive LLC, Provides Increased Energy Production According to Recent Studies
3. Sharp spike in computer-related injuries predicted for medical workers, find studies
4. Analysis of conflicting fish oil studies finds that omega-3 fatty acids still matter
5. Studies from 2012 Quality Care Symposium highlight findings in improving quality of cancer care
6. New studies show effects of mammography guideline changes
7. 2 NIH studies show power of epidemiology research; Underscore need to address health disparities
8. Scripps studies show community-based diabetes programs are key to lowered costs and improved care
9. Cancer Drug Reduced Relapses in MS Patients: Studies
10. University of Houston India Studies Program presents Circuits of Empire: India as Metropole
11. Studies Show Limits, Promise of Laser Removal of Tattoos
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... 2015 , ... The Asian-Pacific market for rheumatoid arthritis therapeutics reached a value ... a CAGR of over 3.2 percent in the years to come to hit the ... spurred by an anticipated launch of a number of promising pipeline candidates and an ...
(Date:7/6/2015)... ... July 06, 2015 , ... Longevity, the ... partnered with Woodbridge Walk-In Urgent Care to offer on-site health screenings. These ultrasound ... conditions. Screenings are affordable and accurate and run about an hour long with ...
(Date:7/6/2015)... , ... July 06, 2015 , ... ... Carlson & Associates has once again teamed up with Family Emergency Shelter Coalition ... to move toward self-sufficiency. FESCO was created especially to provide emergency services and ...
(Date:7/6/2015)... ... July 06, 2015 , ... The School ... funds to support a three-year effort to reduce rates of diabetes and cardiovascular ... in partnership with the Morehouse School of Medicine’s Prevention Research Center and the ...
(Date:7/6/2015)... , ... July 06, 2015 , ... ... Jeffrey R. Carlson finished his 100th case using SpineFrontier’s® PedFuse® REmind® Screws. The ... Hospital in Newport News, VA. The procedure was an L5-S1 posterior lumbar interbody ...
Breaking Medicine News(10 mins):Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 3Health News:Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 3
... men are more at risk of diseases caused by blood ... of diseases caused by the inappropriate formation of a blood ... and stroke, but the reasons for this are not completely ... California, San Francisco, have used a mouse model of thrombosis ...
... review of 11 anti-seizure drugs that showed double the ... Anti-seizure drugs can cause increased suicidal tendencies in patients, ... 20-member panel of experts voted unanimously to back the ... Food and Drug Administration, the Associated Press ...
... are just a few of the extra costs that ... a new study that will be published in current ... social work at Washington University in St. Louis, found ... children,s special needs have different out-of-pocket health expenditures depending ...
... Today, PRINCETON, N.J., July 10 ... alerts and travel security,information from renowned intelligence ... http://www.securassist.com . The redesigned site, launched today, ... for preventing and,handling travel security emergencies., ...
... reported preliminary total retail drug,store sales for the 5-week, 9-week and 22-week periods ended July 3, 2008., , ... Periods ended July 3, 2008, ... Quarter Year ... to Date to Date (Dollars in millions) ...
... from UCLA and the Veterans Affairs Greater Los Angeles ... wearable artificial kidney, or AWAK, that avoids the complications ... , The design for the peritoneal-based artificial kidney ... loss and other dialysis-related problems is summarized in ...
Cached Medicine News:Health News:JCI online early table of contents: July 10, 2008 2Health News:JCI online early table of contents: July 10, 2008 3Health News:JCI online early table of contents: July 10, 2008 4Health News:JCI online early table of contents: July 10, 2008 5Health News:JCI online early table of contents: July 10, 2008 6Health News:JCI online early table of contents: July 10, 2008 7Health News:JCI online early table of contents: July 10, 2008 8Health News:Epilepsy Drugs Can Cause Suicidal Tendencies, FDA Panel Finds 2Health News:Epilepsy Drugs Can Cause Suicidal Tendencies, FDA Panel Finds 3Health News:Cost of raising a child with special needs: Where does your state rank? 2Health News:Assist America's New SecurAssist Website Features Top Travel Security Information Powered by iJET 2Health News:Longs Reports Preliminary June Retail Drug Store Sales 2Health News:Researchers design model for automated, wearable artificial kidney 2
(Date:7/6/2015)... Research and Markets( http://www.researchandmarkets.com/research/45v9b3/urinary_slings ... Slings Market in the US 2015-2019" report to ... Slings market in the US to grow at a ... This report covers the present scenario and the growth ... for the period 2015-2019. To calculate the market size, ...
(Date:7/6/2015)... , July 6, 2015 Array BioPharma,s ... showcased this past weekend at the 2015 ESMO ... presentation.  At the meeting, data were shared from ... a 100-patient randomized Phase 2 expansion of that ... an EGFR inhibitor, with or without the addition ...
(Date:7/6/2015)... 2015 Akcea Therapeutics, a wholly-owned subsidiary ... announced today that the U.S. Food and Drug ... (ISIS-APOCIII Rx ) for the treatment of patients ... rare genetic disease characterized by extremely high triglyceride ... 2 study published in the NEJM in December ...
Breaking Medicine Technology:United States Urinary Slings Market 2015-2019 - Vaginal Slings (TVT, TOT, and Single-incision) & Male Slings (Artificial Urinary Sphincters) 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: